[1]
Árnem D. B. Bezerra, “Benefits of using Sodium-Glucose Cotransporter 2 Inhibitors in patients after Acute Myocardial Infarction ”, Braz. J. Implantol. Health Sci., vol. 6, no. 5, pp. 93–105, May 2024.